1. 1、国家自然科学基金，《应用动态增强磁共振技术预测颅内夹层动脉瘤的壁间血肿在血管内治疗术后转归的研究》，批准经费：21 万元，项目编号：81801158，已结题；
2. 2、首都卫生科研发展专项，《颅内可吸收密网支架置入实验比格犬动脉内的降解性能及安全性研究》，起止年限：2025 年 01 月至 2027 年 12 月，批准经费：40万元，在研。

[1] Zhang YS, Wang C, Dong LG, et al. Statins Reduce Wall Enhancement at Vessel Wall MRI in Unruptured Vertebrobasilar Dissecting Aneurysms: A Randomized Controlled Trial [J]. Radiology, 2025, 317 (3): e242806. DOI: 10.1148/radiol.242806 (并列第一作者).[2] Zhang YS, Kang H, Tian DC, et al. A randomized controlled trial of statins to reduce inflammation in unruptured cerebral aneurysms [J]. JACC: Cardiovasc Imaging, 2022, 15 (9): 1668-1670. (并列通讯作者)[3] Zhang YS, Wang S, He HW, et al. Serum IL-1, Pyroptosis and Intracranial Aneurysm Wall Enhancement: Analysis Integrating Radiology, Serum Cytokines and Histology [J]. Front Cardiovasc Med, 2022, 9: 818789. DOI: 10.3389/fcvm.2022.818789 (并列一作).[4] Zhang YS, et al. Retreatment With Flow Diverters and Coiling for Recurrent Aneurysms After Initial Endovascular Treatment: A Propensity Score-Matched Comparative Analysis [J]. Front Neurol, 2021, 12: 689743. DOI: 10.3389/fneur.2021.689743 (并列通讯作者).[5] Zhang YS, et al. Clinical and Angiographic Outcomes After Stent-Assisted Coiling of Cerebral Aneurysms With Laser-Cut and Braided Stents: A Comparative Analysis of the Literatures [J]. Front Neurol, 2021, 12: 712458. DOI: 10.3389/fneur.2021.712458 (并列通讯作者).[6] Zhang YS, et al. Endovascular treatment of vertebral and basilar artery aneurysms with low-profile visualized intraluminal support device [J]. BMC Neurol, 2021, 21 (1): 389. DOI: 10.1186/s12883-021-02345-x (并列通讯作者).[7] Zhang YS, et al. Statin treatment for unruptured intracranial aneurysms study: a study protocol for a double-blind, placebo-controlled trial [J]. Stroke Vasc Neurol, 2020, 5 (4): 289-295. DOI: 10.1136/svn-2020-000456 (并列一作).[8] Zhang YS, et al. Dynamic contrast-enhanced MRI analysis for prognosis of intracranial dissecting aneurysm with intramural haematoma after endovascular treatment: an observational registry study [J]. Stroke Vasc Neurol, 2020, 5 (3): 211-218. DOI: 10.1136/svn-2019-000387 (通讯作者).[9] Zhang YS, et al. Endovascular treatment of bilateral intracranial vertebral artery aneurysms: an algorithm based on a 10-year neurointerventional experience [J]. Stroke Vasc Neurol, 2020, 5 (2): 145-152. DOI: 10.1136/svn-2019-000352 (第一作者).[10] Zhang YS, et al. Outcomes in Symptomatic Patients With Vertebrobasilar Dolichoectasia Following Endovascular Treatment [J]. Front Neurol, 2019, 10: 1123. DOI: 10.3389/fneur.2019.01123 (并列通讯作者).[11] Zhang YS, et al. Application of the Pipeline Embolization Device for Giant Vertebrobasilar Dissecting Aneurysms in Pediatric Patients [J]. Front Neurol, 2019, 10: 987. DOI: 10.3389/fneur.2019.00987 (并列一作).[12] Zhang YS, et al. Endovascular Treatment of Large or Giant Non-saccular Vertebrobasilar Aneurysms: Pipeline Embolization Devices Versus Conventional Stents [J]. Front Neurol, 2019, 10: 845. DOI: 10.3389/fneur.2019.00845 (并列通讯作者).[13] Zhang YS, et al. A Modified Endovascular Treatment Protocol for Iatrogenic Internal Carotid Artery Injuries following Endoscopic Endonasal Surgery [J]. J Neurosurg, 2018, 130 (4): 1234-1241. DOI: 10.3171/2017.9.JNS171289 (并列一作).[14] Zhang YS, et al. Aneurysm wall enhancement on magnetic resonance imaging as a risk factor for progression of unruptured vertebrobasilar dissecting aneurysms after reconstructive endovascular treatment [J]. J Neurosurg, 2017, 127 (3): 789-796. DOI: 10.3171/2016.6.JNS160875 (第一作者).